Details of the Drug Combinations

General Information of This Drug (ID: DMXQRU1)

Drug Name

Simethicone DMXQRU1

Synonyms

Phazyme; Antifoam A; DC antifoam A; Sentry Simethicone; Mylanta Gas Relief; Gas-X; Rioplus; Mylicon Infant's Drops; Simeco; Asidopan Plus; Wydrate Plus; Riopan Plus; Sentry Simethicone Emulsion; 8050-81-5; HSDB 3906; Silicone antifoam agent S 184; Silicone antifoam emulsions SE 6 and SE 9; alpha-(Trimethylsilyl)-omega-methylpoly(oxy(dimethylsilylene)), mixture with silicon dioxide; Disflatyl; Sab Simplex; Simethicone [USAN]; Simethicone [USAN:USP]; SIMETICONE; AC1O5GCS; SCHEMBL339371; LS-145411; FT-0674588; 24135-EP2305254A1

Indication

Disease Entry	ICD 11	Status	REF
Dyspepsia	MD92	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Bisacodyl + Simethicone	DC95ERL	Bisacodyl	Constipation	[2]
Loperamide + Simethicone	DC1RF6P	Loperamide	Relapsing Remitting Multiple Sclerosis	[3]
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	ClinicalTrials.gov (NCT02211976) Efficacy and Tolerability of Bisacodyl Sugar Coated Tablets, Simeticone Chewing Tablets and Their Combination in Constipation and Bloatedness
3	ClinicalTrials.gov (NCT02217982) Pilot Study to Assess Dimethyl Fumarate Related GI Symptom Mitigation